---
schema_version: "secwatch.filing_event.v1"
accession: "0001730463-25-000022"
form_type: "8-K"
ticker: "AUTL"
cik: "0001730463"
company_name: "Autolus Therapeutics plc"
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:18:23.086280+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Autolus schedules R&D investor event with corporate update; no specific data disclosed

## Summary
- Corporate update presented at R&D investor event on April 23, 2025.
- Presentation slides available on Autolus website after conclusion.
- No financial results, pipeline updates, or guidance provided in filing.

## SEC filing metadata
- accession: 0001730463-25-000022
- form_type: 8-K
- ticker: AUTL
- cik: 0001730463
- company_name: Autolus Therapeutics plc
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730463/000173046325000022/0001730463-25-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730463/000173046325000022/autl-20250423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001730463-25-000022
- JSON: https://secwatch.observer/filing/0001730463-25-000022.json
- Plain text: https://secwatch.observer/filing/0001730463-25-000022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.